Events and Presentations Events and Presentations Past Events Piper Jaffray 31st Annual Healthcare Conference Dec 3, 2019 at 2:00 PM EST Click Here for Webcast Webcast Event at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting Nov 9, 2019 at 6:30 PM EST Click here for webcast Morgan Stanley 17th Annual Global Healthcare Conference – Fireside Chat with: NextCure (NXTC) Sep 10, 2019 at 10:00 AM EDT Click here for webcast Presentations Corporate Presentation - December 2019 NextCure Presents Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of SITC NextCure Hosts and Webcast Event at the 34th Annual Meeting of SITC NextCure Presents Preclinical Data on NC318, a Novel Immunomedicine Targeting Siglec-15, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting (PDF) Tools
Events and Presentations Past Events Piper Jaffray 31st Annual Healthcare Conference Dec 3, 2019 at 2:00 PM EST Click Here for Webcast Webcast Event at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting Nov 9, 2019 at 6:30 PM EST Click here for webcast Morgan Stanley 17th Annual Global Healthcare Conference – Fireside Chat with: NextCure (NXTC) Sep 10, 2019 at 10:00 AM EDT Click here for webcast Presentations Corporate Presentation - December 2019 NextCure Presents Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of SITC NextCure Hosts and Webcast Event at the 34th Annual Meeting of SITC NextCure Presents Preclinical Data on NC318, a Novel Immunomedicine Targeting Siglec-15, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting (PDF)
Webcast Event at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting Nov 9, 2019 at 6:30 PM EST Click here for webcast
Morgan Stanley 17th Annual Global Healthcare Conference – Fireside Chat with: NextCure (NXTC) Sep 10, 2019 at 10:00 AM EDT Click here for webcast
NextCure Presents Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of SITC
NextCure Presents Preclinical Data on NC318, a Novel Immunomedicine Targeting Siglec-15, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting (PDF)
